系统性硬化症患者的身体成分是否重要?
Chiara Giraudo1, Giulia Fichera1, Marco Binda2
1Unit of Advanced Clinical and Translational Imaging, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova University Hospital, Padova, Italy.
Rheumatology (Oxford, England)
|May 23, 2025
概括
身体构成显著影响硬化皮肤病 (SSc) 患者的治疗结果. 骨髓炎和低肌肉质量预测死亡率,强调在SSc管理中需要对身体组成进行评估.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 放射学 放射学是指放射学
- 身体组成分析 身体成分分析
背景情况:
- 身体组成,包括肌肉质量和脂肪组织,越来越多地被认为在风湿和自身炎症性疾病中的作用.
- 硬化皮质 (SSc) 是一种复杂的自身免疫性疾病,具有显著的系统影响,其中身体组成因素可能会影响疾病的进展和患者的结果.
研究的目的:
- 评估肌肉质量和皮下脂肪组织质量和数量的对系统性硬化症 (SSc) 患者死亡率的影响.
- 确定身体组成指标作为SSc患者死亡率的预测指标.
主要方法:
- 包括接受高分辨率胸部CT (HRCT) 的成年SSc患者.
- 半自动细分用于分析第12个背脊椎的皮下脂肪和椎肌肉,量化面积和密度.
- 使用逐步线性回归和概率风险比率来评估死亡率的预测因素,包括骨髓炎 (肌肉脂肪透).
主要成果:
- 肺部对一氧化碳 (DLCO) 的扩散能力较低,BMI较高,皮下脂肪密度增加,骨肌肉指数较低预测SSc患者的死亡率.
- 在SSc患者中,相当一部分 (72%) 呈现肌肉骨病 (肌肉脂肪透).
- 肌肉脂肪透与3345倍高的死亡风险有关.
结论:
- 系统性硬化症患者经常出现骨髓炎和sarcopenia前期.
- 身体组成参数,特别是肌肉质量和数量,似乎显著影响SSc.的整体预后和生存时间.
相关概念视频
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
01:26Atherosclerosis III: Management
322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
01:21Drug Dosing: Obese Patients
226
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
226
01:22Connective Tissue Cell Types
4.0K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
4.0K
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
472
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
472